Last $11.42 USD
Change Today -0.06 / -0.52%
Volume 156.4K
MNTA On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 5:10 PM 12/24/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Marsha H. Fanucci

Independent Director, Chairman of Audit Committee and Member of Nominating & Corporate Governance Committee, Momenta Pharmaceuticals Inc.
AgeTotal Calculated CompensationThis person is connected to 61 board members in 4 different organizations across 5 different industries.

See Board Relationships
60$204,072

Background*

Ms. Marsha H. Fanucci served as Senior Vice President and Chief Financial Officer of Millennium Pharmaceuticals Inc., since July 2004 and also served as its Principal Accounting Officer. Ms. Fanucci served as Senior Vice President, Finance and Corporate Strategy of Millennium Pharmaceuticals Inc. from October 2003 to July 2004, Vice President of Finance and Corporate Strategy from July 2003 to October 2003 and Vice President, Corporate Development from July 2000 to July ...

Read Full Background

Corporate Headquarters*

675 West Kendall Street
Cambridge, Massachusetts 02142

United States

Phone: 617-491-9700
Fax: 617-621-0431

Board Members Memberships*

2005-Present
Independent Director, Chairman of Audit Committee and Member of Nominating & Corporate Governance Committee
2009-Present
Director and Chairman of Audit Committee
2010-Present
Director, Member of Audit Committee and Member of Nominating & Corporate Governance Committee
2014-Present
Director and Chairman of Audit Committee

Education*

MBA
Northeastern University
BS
West Virginia University School of Medicine

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$66,000
Total Calculated Compensation$204,072
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MNTA:US $11.42 USD -0.06

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Friedhelm Blobel Ph.D.Chief Executive Officer, President, Executive Director and Member of Business Development Committee
SciClone Pharmaceuticals, Inc.
$550.0K
Douglas A. Michels Chief Executive Officer, President and Director
OraSure Technologies, Inc.
$563.4K
Peter S. Greenleaf Chief Executive Officer, Director, Member of Commercialization Committee and Member of Science & Technology Committee
Sucampo Pharmaceuticals, Inc.
--
Rajeev Nannapaneni Vice Chairman, Chief Executive Officer, Chief Operating Officer and Member of Allotment Committee
Natco Pharma Limited
--
Douglas L. Drysdale Chairman, Chief Executive Officer and President
Pernix Therapeutics Holdings, Inc.
--
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MOMENTA PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.